165 related articles for article (PubMed ID: 26087285)
1. Development of a Multiplex PCR Test with Automated Genotyping Targeting E7 for Detection of Six High-Risk Human Papillomaviruses.
Paes EF; de Assis AM; Teixeira CS; Aoki FH; Teixeira JC
PLoS One; 2015; 10(6):e0130226. PubMed ID: 26087285
[TBL] [Abstract][Full Text] [Related]
2. Establishment and Application of a Method for High-Risk Human Papillomavirus Genotyping in Cervical Cancer Tissue.
Zou R; Xie W; Wang H; Wang J; Xiao L; Ji S; Chen X; Zhang L; Xue X; Chen J
Clin Lab; 2016; 62(6):1075-85. PubMed ID: 27468570
[TBL] [Abstract][Full Text] [Related]
3. CIN2+ detection of the HPV DNA Array genotyping assay in comparison with the Cobas 4800 HPV test and cytology.
Pesic A; Krings A; Hempel M; Preyer R; Chatzistamatiou K; Agorastos T; Kaufmann AM
Virol J; 2019 Jul; 16(1):92. PubMed ID: 31337408
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the SureX HPV genotyping test for the detection of high-risk HPV in cervical cancer screening.
Wei B; Mei P; Huang S; Yu X; Zhi T; Wang G; Xu X; Xiao L; Dong X; Cui W
Virol J; 2020 Nov; 17(1):171. PubMed ID: 33168022
[TBL] [Abstract][Full Text] [Related]
5. Clinical validation of the Cobas 4800 HPV assay using cervical samples in SurePath medium under the VALGENT4 framework.
Ejegod DM; Hansen M; Christiansen IK; Pedersen H; Quint W; Xu L; Arbyn M; Bonde J
J Clin Virol; 2020 Jul; 128():104336. PubMed ID: 32446166
[TBL] [Abstract][Full Text] [Related]
6. Use of Multiplex Polymerase Chain Reaction for Detection of High-Risk Human Papillomavirus Genotypes in Women Attending Routine Cervical Cancer Screening in Harare.
Marembo T; Dube Mandishora R; Borok M
Intervirology; 2019; 62(2):90-95. PubMed ID: 31412350
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a Novel Single-Tube Method for Extended Genotyping of Human Papillomavirus.
Bhatia R; Serrano I; Wennington H; Graham C; Cubie H; Boland E; Fu G; Cuschieri K
J Clin Microbiol; 2018 Mar; 56(3):. PubMed ID: 29237790
[TBL] [Abstract][Full Text] [Related]
8. HPV genotype determination and E6/E7 mRNA detection for management of HPV positive women.
Bruno MT; Ferrara M; Fava V; Rapisarda A; Coco A
Virol J; 2018 Mar; 15(1):52. PubMed ID: 29587778
[TBL] [Abstract][Full Text] [Related]
9. Eight-type human papillomavirus E6/E7 oncoprotein detection as a novel and promising triage strategy for managing HPV-positive women.
Rezhake R; Hu SY; Zhao S; Xu XQ; Zhao XL; Zhang L; Wang Y; Zhang X; Pan QJ; Qiao YL; Zhao FH
Int J Cancer; 2019 Jan; 144(1):34-42. PubMed ID: 29943809
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a multiplex qPCR assay for detection and relative quantification of HPV16 and HPV18 E6 and E7 oncogenes.
Bordigoni A; Motte A; Tissot-Dupont H; Colson P; Desnues C
Sci Rep; 2021 Feb; 11(1):4039. PubMed ID: 33597592
[TBL] [Abstract][Full Text] [Related]
11. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
[TBL] [Abstract][Full Text] [Related]
12. Analytical comparison of the cobas HPV Test with Hybrid Capture 2 for the detection of high-risk HPV genotypes.
Lindemann ML; Dominguez MJ; de Antonio JC; Sandri MT; Tricca A; Sideri M; Khiri H; Ravet S; Boyle S; Aldrich C; Halfon P
J Mol Diagn; 2012 Jan; 14(1):65-70. PubMed ID: 22079749
[TBL] [Abstract][Full Text] [Related]
13. Detection of Circulating HPV16 DNA as a Biomarker for Cervical Cancer by a Bead-Based HPV Genotyping Assay.
Galati L; Combes JD; Le Calvez-Kelm F; McKay-Chopin S; Forey N; Ratel M; McKay J; Waterboer T; Schroeder L; Clifford G; Tommasino M; Gheit T
Microbiol Spectr; 2022 Apr; 10(2):e0148021. PubMed ID: 35225653
[TBL] [Abstract][Full Text] [Related]
14. Comparison of human papillomavirus detection by Aptima HPV and cobas HPV tests in a population of women referred for colposcopy following detection of atypical squamous cells of undetermined significance by Pap cytology.
Castle PE; Eaton B; Reid J; Getman D; Dockter J
J Clin Microbiol; 2015 Apr; 53(4):1277-81. PubMed ID: 25653409
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the analytical and clinical performance of five tests for the detection of human papillomavirus genital infection.
Del Pino M; Alonso I; Rodriguez-Trujillo A; Bernal S; Geraets D; Guimerà N; Torne A; Ordi J
J Virol Methods; 2017 Oct; 248():238-243. PubMed ID: 28739302
[TBL] [Abstract][Full Text] [Related]
16. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
[TBL] [Abstract][Full Text] [Related]
17. A comparison of early (E7) and late (L1) primer-mediated amplification of papillomaviral DNA in cervical neoplasia.
Tate JE; Yang YC; Shen J; McLachlin CM; Sheets EE; Crum CP
Mol Cell Probes; 1996 Oct; 10(5):347-51. PubMed ID: 8910889
[TBL] [Abstract][Full Text] [Related]
18. Comparison of three human papillomavirus DNA detection methods: Next generation sequencing, multiplex-PCR and nested-PCR followed by Sanger based sequencing.
da Fonseca AJ; Galvão RS; Miranda AE; Ferreira LC; Chen Z
J Med Virol; 2016 May; 88(5):888-94. PubMed ID: 26496186
[TBL] [Abstract][Full Text] [Related]
19. Development of a fluorescence-based multiplex genotyping method for simultaneous determination of human papillomavirus infections and viral loads.
Sun Z; Zhang R; Liu Z; Liu C; Li X; Zhou W; Yang L; Ruan Q; Zhang X
BMC Cancer; 2015 Nov; 15():860. PubMed ID: 26546160
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the Roche Linear Array HPV Genotyping Test within the VALGENT framework.
Xu L; Oštrbenk A; Poljak M; Arbyn M
J Clin Virol; 2018 Jan; 98():37-42. PubMed ID: 29241150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
